Faster global financial news!
AbbVie
-
AbbVie highlights growth drivers SKYRIZI and RINVOQ, pipeline catalysts, and maintained high-single-digit revenue growth outlook at Wells Fargo conference
AbbVie executives outlined growth plans across immunology, oncology, and neuroscience at a Wells Fargo conference, emphasizing continued momentum for its SKYRIZI and RINVOQ franchises, a pipeline of c
-
AbbVie is considered a better healthcare stock pick than Johnson & Johnson for 2026, with its net income projected to surge to $14.6 billion.
An analysis from Yahoo Finance highlights AbbVie's impressive R&D pipeline and higher upside potential, projecting its net income to surge from $4.2 billion to $14.6 billion this fiscal year, with sal
-
Yahoo Finance analysis points out that three healthcare stocks, Eli Lilly, Johnson & Johnson, and AbbVie, are worth watching in August due to their relatively poor market performance but strong fundamentals.
The analysis suggests that although the healthcare sector has underperformed the S&P 500 year-to-date, it has led all sectors over the past three months. Specifically, Eli Lilly's Q2 revenue increased
-
JPMorgan says one of the market’s ‘most durable growth’ sectors has been passed over for AI
JPMorgan states that one of the market’s “most durable growth” sectors has been overlooked by investors in favor of artificial intelligence (AI). The bank lists Eli Lilly, AbbVie, and Danaher Corporat
-
AbbVie highlights growth drivers SKYRIZI and RINVOQ, pipeline catalysts, and maintained high-single-digit revenue growth outlook at Wells Fargo conference
AbbVie executives outlined growth plans across immunology, oncology, and neuroscience at a Wells Fargo conference, emphasizing continued momentum for its SKYRIZI and RINVOQ franchises, a pipeline of c
-
AbbVie is considered a better healthcare stock pick than Johnson & Johnson for 2026, with its net income projected to surge to $14.6 billion.
An analysis from Yahoo Finance highlights AbbVie's impressive R&D pipeline and higher upside potential, projecting its net income to surge from $4.2 billion to $14.6 billion this fiscal year, with sal
-
Yahoo Finance analysis points out that three healthcare stocks, Eli Lilly, Johnson & Johnson, and AbbVie, are worth watching in August due to their relatively poor market performance but strong fundamentals.
The analysis suggests that although the healthcare sector has underperformed the S&P 500 year-to-date, it has led all sectors over the past three months. Specifically, Eli Lilly's Q2 revenue increased
-
JPMorgan says one of the market’s ‘most durable growth’ sectors has been passed over for AI
JPMorgan states that one of the market’s “most durable growth” sectors has been overlooked by investors in favor of artificial intelligence (AI). The bank lists Eli Lilly, AbbVie, and Danaher Corporat
- No data
AbbVie
24H Trending
-
1
Aethir (ATH) Token Value Analysis: Decentralized Cloud Computing Project Potential and Risk Assessment
-
2
Bitcoin rises above $77,000, bucking tech selloff driven by AI safety concerns and rising oil prices
-
3
Guyana's President: Oil Revenue Surges Due to Iran Conflict
-
4
NOAH Coin Analysis: Distinguishing Between Controversial Projects and Active Payment Infrastructure
-
5
RIKEN Coin Value Analysis: Numerous Projects Share the Same Name, What's Its Investment Potential?
-
6
FXBK Coin Analysis: What Is It? Is It Worth Investing In?
-
7
Cosco Shipping Heavy Industry Completes China IPO Guidance Registration
-
8
Beginner's Guide to Bitcoin Trading: A Comprehensive Analysis of Security Risks and Prevention Strategies
-
9
Taiwan to open second quasi-diplomatic mission in the Philippines, sources say
-
10
Samsung Display develops world's first 6.9-inch mobile OLED panel with 2K resolution, 165Hz refresh rate, and 30% lower power consumption
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
